Novo Nordisk has been made aware of some Ozempic® and Saxenda® pens in Uzbekistan, Azerbaijan and Kazakhstan that have been falsified and are not legitimate. The falsified products have been sold both within the legal and illegal supply chain. The content of the falsified pens is entirely different from the genuine products and should not be used as the falsified pens pose a risk to patients’ safety.
The main difference between the counterfeit product and the genuine product is that the genuine Novo Nordisk Ozempic® and Saxenda® pens do not extend or increase in length when setting the dose. The scale drum increments are fixed doses, such as 0.25 mg, 0.5 mg, and 1.0 mg for Ozempic® and 0.6 mg, 1.2 mg, 1.8 mg, 2.4 mg and 3.0 mg for Saxenda®.
A falsified pen can be identified based on scale going from 0 to 80 units and extending out from the pen when setting the dose.
- Be aware of the risk of falsified products and check your product carefully before using.
- If you discover a falsified product do not use it and please contact io-rom-safety@novonordisk.com, or +994124047696.
- If you have used a product you suspect to be falsified, seek medical advice immediately.
Patient safety is a top priority for Novo Nordisk and we are in close dialogue with all relevant stakeholders to support patients in the best possible way against falsified products.
If you have any questions, please contact io-rom-safety@novonordisk.com or call +994124047696.
In case of a severe side effect taking place, seek immediate help from your local hospital or healthcare professional.
If you have experienced a side effect or technical complaint to a Novo Nordisk product, we encourage you to also report this to Novo Nordisk.
All medicines have potential side effects as well as benefits. We routinely monitor the safety and quality of all our products. This includes review of safety data from clinical studies and review of side effects and technical complaints. By monitoring quality and safety information on our products, we can take due and appropriate actions to safeguard patient safety.
Fulfilling its responsibilities in the field of pharmacovigilance, the company asks doctors and patients to report all cases of adverse events and technical complaints observed with the use of Novo Nordisk products. The message will be processed by the Pharmacovigilance Specialist.
Telephone number: +994 12 404 76 96
To access your profile outside of the application process you will need to select a position on the website and click Apply now. Once you click Apply now you will be routed to the position page where you can select View Profile from the top menu bar, sign in and open the Jobs Applied accordion.
After you sign in you will be able to view the position(s) to which you have applied, view your application(s) and the status of your application(s).
After your log into your profile you will be taken to the candidate profile screen where you can select My Documents.
Here you can upload from a device, drop box or google drive. Note, you can only maintain one resume on file at a time.
Talent Acquisition will review your resume and interest in conjunction with the requirements of the role. If there is interest in having you move forward in the process you will be contacted by a Novo Nordisk Talent Acquisition Representative regarding next steps.
As a reminder, you can always view the status of your application by navigating to View Profile and selecting Jobs Applied.
You can always view your application status once you log into the
system and select View Profile and by selecting Jobs
Applied.